Cargando…
The quest for the holy grail: new antitubercular chemical entities, targets and strategies
Tuberculosis (TB) remains the leading cause of death from an infectious disease worldwide. TB therapy is complicated by the protracted treatment regimens, development of resistance coupled with toxicity and insufficient sterilizing capacity of current drugs. Although considerable progress has been m...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd. ;, Distributed by Virgin Mailing and Distribution
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215093/ https://www.ncbi.nlm.nih.gov/pubmed/32062007 http://dx.doi.org/10.1016/j.drudis.2020.02.003 |
_version_ | 1783532107202560000 |
---|---|
author | Huszár, Stanislav Chibale, Kelly Singh, Vinayak |
author_facet | Huszár, Stanislav Chibale, Kelly Singh, Vinayak |
author_sort | Huszár, Stanislav |
collection | PubMed |
description | Tuberculosis (TB) remains the leading cause of death from an infectious disease worldwide. TB therapy is complicated by the protracted treatment regimens, development of resistance coupled with toxicity and insufficient sterilizing capacity of current drugs. Although considerable progress has been made on establishing a TB drug pipeline, the high attrition rate reinforces the need to continually replenish the pipeline with high-quality leads that act through inhibition of novel targets. In this review, we highlight some of the key advances that have assisted TB drug discovery with novel chemical matter, targets and strategies – to fuel the TB drug pipeline. |
format | Online Article Text |
id | pubmed-7215093 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Science Ltd. ;, Distributed by Virgin Mailing and Distribution |
record_format | MEDLINE/PubMed |
spelling | pubmed-72150932020-05-13 The quest for the holy grail: new antitubercular chemical entities, targets and strategies Huszár, Stanislav Chibale, Kelly Singh, Vinayak Drug Discov Today Article Tuberculosis (TB) remains the leading cause of death from an infectious disease worldwide. TB therapy is complicated by the protracted treatment regimens, development of resistance coupled with toxicity and insufficient sterilizing capacity of current drugs. Although considerable progress has been made on establishing a TB drug pipeline, the high attrition rate reinforces the need to continually replenish the pipeline with high-quality leads that act through inhibition of novel targets. In this review, we highlight some of the key advances that have assisted TB drug discovery with novel chemical matter, targets and strategies – to fuel the TB drug pipeline. Elsevier Science Ltd. ;, Distributed by Virgin Mailing and Distribution 2020-04 /pmc/articles/PMC7215093/ /pubmed/32062007 http://dx.doi.org/10.1016/j.drudis.2020.02.003 Text en © 2020 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Huszár, Stanislav Chibale, Kelly Singh, Vinayak The quest for the holy grail: new antitubercular chemical entities, targets and strategies |
title | The quest for the holy grail: new antitubercular chemical entities, targets and strategies |
title_full | The quest for the holy grail: new antitubercular chemical entities, targets and strategies |
title_fullStr | The quest for the holy grail: new antitubercular chemical entities, targets and strategies |
title_full_unstemmed | The quest for the holy grail: new antitubercular chemical entities, targets and strategies |
title_short | The quest for the holy grail: new antitubercular chemical entities, targets and strategies |
title_sort | quest for the holy grail: new antitubercular chemical entities, targets and strategies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215093/ https://www.ncbi.nlm.nih.gov/pubmed/32062007 http://dx.doi.org/10.1016/j.drudis.2020.02.003 |
work_keys_str_mv | AT huszarstanislav thequestfortheholygrailnewantitubercularchemicalentitiestargetsandstrategies AT chibalekelly thequestfortheholygrailnewantitubercularchemicalentitiestargetsandstrategies AT singhvinayak thequestfortheholygrailnewantitubercularchemicalentitiestargetsandstrategies AT huszarstanislav questfortheholygrailnewantitubercularchemicalentitiestargetsandstrategies AT chibalekelly questfortheholygrailnewantitubercularchemicalentitiestargetsandstrategies AT singhvinayak questfortheholygrailnewantitubercularchemicalentitiestargetsandstrategies |